Contemporary Management of <i>Staphylococcus aureus</i> Bacteremia—Controversies in Clinical Practice-Reference-Cited by-同舟云学术

Contemporary Management of Staphylococcus aureus Bacteremia—Controversies in Clinical Practice

Published:2023-11-10 Issue:11 Volume:77 Page:e57-e68
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Minter Daniel J¹^ORCID,Appa Ayesha¹²^ORCID,Chambers Henry F¹²,Doernberg Sarah B¹

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, University of California, San Francisco , San Francisco, California , USA

2. Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital, Department of Medicine, University of California, San Francisco , San Francisco, California , USA

Abstract

Abstract Staphylococcus aureus bacteremia (SAB) carries a high risk for excess morbidity and mortality. Despite its prevalence, significant practice variation continues to permeate clinical management of this syndrome. Since the publication of the 2011 Infectious Diseases Society of America (IDSA) guidelines on management of methicillin-resistant Staphylococcus aureus infections, the field of SAB has evolved with the emergence of newer diagnostic strategies and therapeutic options. In this review, we seek to provide a comprehensive overview of the evaluation and management of SAB, with special focus on areas where the highest level of evidence is lacking to inform best practices.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad500/53252807/ciad500.pdf

Reference118 articles.

1. Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States;Kourtis;MMWR Morb Mortal Wkly Rep,2019

2. Patients' experiences with Staphylococcus aureus and gram-negative bacterial bloodstream infections: a qualitative descriptive study and concept elicitation phase to inform measurement of patient-reported quality of life;King;Clin Infect Dis,2021

3. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019;GBD 2019 Antimicrobial Resistance Collaborators;Lancet Lond Engl,2022

4. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children;Liu;Clin Infect Dis,2011

5. Redefining Staphylococcus aureus bacteremia: a structured approach guiding diagnostic and therapeutic management;Kouijzer;J Infect,2023

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: A clinical perspective;npj Imaging;2024-09-13

2. Infections in cirrhosis;The Lancet Gastroenterology & Hepatology;2024-08

3. Adherence to and clinical utility of “quality indicators” for Staphylococcus aureus bacteremia: a retrospective, multicenter study;Infection;2024-05-10

4. The Positioning of Ceftobiprole in Staphylococcus aureus Bacteremia;Clinical Infectious Diseases;2024-03-11

5. Adherence to and clinical utility of “Quality Indicators” for Staphylococcus aureus bacteremia; a retrospective, multicenter study;2024-02-23